首页> 外文期刊>Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease >Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy
【24h】

Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy

机译:Alirocumab抑制PCSK9对核磁共振波谱法测定脂蛋白颗粒浓度的影响

获取原文

摘要

Background In patients with discordance between low‐density lipoprotein (LDL) cholesterol and LDL particle (LDL‐P) concentrations, cardiovascular risk more closely correlates with LDL?P.
机译:背景低密度脂蛋白(LDL)胆固醇和LDL颗粒(LDL-P)浓度不一致的患者中,心血管风险与LDL?P密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号